BigHat Biosciences alternatives and competitors
The closest alternatives to BigHat Biosciences are Absci, Nabla Bio, Generate:Biomedicines and Cradle.
BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
10 alternatives to BigHat Biosciences
What each product does, with its price as the vendor publishes it.
-
A
Absci designs antibodies with generative AI and develops them as its own medicines and with partners.
Price: No published price
-
N
Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab.
Price: No published price
-
G
Generate:Biomedicines, a Somerville, Massachusetts company founded by Flagship Pioneering in 2018 and listed on Nasdaq since February 2026, designs protein medicines with machine learning rather than finding them in nature.
Price: Not applicable
-
C
Protein engineering software company, based in Amsterdam and Zurich, that licenses an AI platform directly to R&D teams rather than working through discovery partnerships.
Price: No published price
-
I
immunitoAI designs antibody drugs with AI and tests the designs in its own laboratory.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
I
Isomorphic Labs is a London based AI drug design company founded in 2021 by Sir Demis Hassabis, who leads it as chief executive.
Price: Not applicable
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
B
Biolojic Design uses machine learning to design antibodies that do more than block a target: epitope specific agonists and antagonists, conditional binders, and what it calls multibodies, single symmetrical antibodies that bind more than one target on the same arm.
Price: No published price
-
L
LabGenius designs antibody drugs for cancer using a machine learning engine wired into its own robotic lab, and develops them through a mix of partnerships and a wholly owned pipeline.
Price: No published price
BigHat Biosciences alternatives, answered
What are the best alternatives to BigHat Biosciences?
The closest alternatives to BigHat Biosciences are Absci, Nabla Bio, Generate:Biomedicines, Cradle and immunitoAI. Absci designs antibodies with generative AI and develops them as its own medicines and with partners. Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab. Generate:Biomedicines, a Somerville, Massachusetts company founded by Flagship Pioneering in 2018 and listed on Nasdaq since February 2026, designs protein medicines with machine learning rather than finding them in nature.
Who are BigHat Biosciences's competitors?
BigHat Biosciences's competitors in the Drug Discovery AI category include Absci, Nabla Bio, Generate:Biomedicines, Cradle, immunitoAI and Superluminal Medicines.